 Proposal: A 4-week clinical trial of 60 atopic dermatitis patients ages 9 months to 17 years would be conducted. All sixty patients would be given topical mid-potency corticosteroid Locoid lipocream to be mixed with a second product. Half the patients would receive Altabax and the other half would receive vehicle blinded to subject and investigator. Patients would be advised to apply the topical randomized product first, let dry and then apply topical Locoid lipocream to affected areas, and then apply the topical randomized ointment product to each of the sites of skin disease on top of the Locoid lipocream . Treatment of affected areas would continue for 4 weeks or until lesions have cleared, which ever comes first. Parents of patients will be asked to maintain a written diary of drug application. 